Sign in

Kate Thomson

@k-jt.bsky.social
131 followers 281 following 0 posts

NHS Clinical Scientist. Inherited cardiac conditions. Genomics in healthcare. Oxford.

PostsRepliesMedia
Reposted by Kate Thomson
Caroline Wright @carolinefwright.bsky.social · 08/10/2026
Do you have thoughts on how whole-genome sequencing should be used in newborn screening? We're doing a survey on Genomic Newborn Screening in Public Health @nihrexeterbrc.bsky.social, and would love to hear a diversity of opinions - no prior knowledge needed! Participate here: tinyurl.com/genomicnbs
tinyurl.com
Microsoft Forms
025
Reposted by Kate Thomson
Peter van Tintelen @jpvantintelen.bsky.social · 23/03/2026
Genetic testing has become an integral part of the diagnostic workup of patients with dilated cardiomyopathy. New clinical consensus paper provides insights on how to implement it in the clinical practice. academic.oup.com/eurheartj/ad...
academic.oup.com
Validate User
022
Reposted by Kate Thomson
European Society of Human Genetics @eshg.bsky.social · 26/06/2025
Episode 4 of the ESHG Webinar Series is now available on YouTube! Kaitlin Samocha discusses how population data can improve variant interpretation, with a focus on rare disease. 📺 Watch the recording: youtu.be/pWhienkM6L4?... #Genomics #RareDisease #VariantInterpretation #ESHG
youtu.be
083
Reposted by Kate Thomson
Mike Hubank @generoom.bsky.social · 24/06/2025
I'm not against preventative screening, if done appropriately, but all this money for preemptive WGS at a time when our budget for #genomic testing patients *who actually have a disease* is being cut by 10%? Explain that to me someone.
032
Reposted by Kate Thomson
Anneke Lucassen @alucassen.bsky.social · 22/06/2025
Evaluation of generation study (newborn genomes ‘pilot’) not yet done, so why announce it’s being rolled out to all babies?? We tried to make sense of issues involved cpm.ox.ac.uk/wp-content/u... and cpm.ox.ac.uk/event/newbor... led by excellent @rachel-horton.bsky.social @cpmoxford.bsky.social
cpm.ox.ac.uk
Making progress with newborn screening - cpm
This event explored some of the challenges around balancing the benefits of extending screening for babies with rare conditions, with the involvement this requires from babies who do not stand to pers...
186
Reposted by Kate Thomson
The Heart Hive @thehearthive.bsky.social · 05/06/2025
We want to learn more about the genetics of cardiomyopathy. Are you over 18, in the UK and interested in taking part in research? Go to thehearthive.org to learn more about the Heart Hive Cardiomyopathy Study.
011
Reposted by Kate Thomson
Jodie Ingles @jodieingles27.bsky.social · 17/04/2025
Our paper now published! 🙌🏻🧬🫀 @alexbutters25.bsky.social @k-jt.bsky.social @njhenden.bsky.social @dgmacarthur.bsky.social @kathrynmcgurk.bsky.social @jamesware.bsky.social @sharday-penn.bsky.social @rdbagnall.bsky.social @garvaninstitute.bsky.social @escardio.bsky.social doi.org/10.1093/eurh...
doi.org
A rare splice-site variant in TNNT2: the need for ancestral diversity in genomic reference data sets
Inherited cardiomyopathies, including hypertrophic (HCM), dilated (DCM), and restrictive (RCM) cardiomyopathies affect ∼1 in 200–500 in the population. Gen
12911
Reposted by Kate Thomson
Chai Ann Ng @chaiannng.bsky.social · 27/03/2025
I am pleased to share this @ahajournals.bsky.social CircGen paper. It is a team effort. I hope we have provided valuable insights on how KCNH2 variant that alters splicing and causes a large in-frame deletion can lead to a dominant negative effect of Kv11.1 K+ #ionchannel function.
ahajournals.org
Combined RNA Splicing and Patch-Clamp Analysis Reveal Pathogenicity of Splice-Altering Variants in KCNH2-Related LQTS | Circulation: Genomic and Precision Medicine
075
Reposted by Kate Thomson
Nicky Whiffin @nickywhiffin.bsky.social · 26/03/2025
I am giving an online webinar in an hour for @eshg.bsky.social, if anyone is interested and free 👇
082
Reposted by Kate Thomson
Andrew Glazer @amglazer.bsky.social · 20/03/2025
🧵 I’m excited to share our latest preprint! We studied 252 SCN5A variants found in patients with Brugada Syndrome by automated patch clamp. [1/7]
1135
Reposted by Kate Thomson
Daniel MacArthur @dgmacarthur.bsky.social · 15/03/2025
New preprint! We worked with @msftresearch.bsky.social and @broadinstitute.org to see whether large language models (LLMs) can be useful to variant scientists in deciding whether genetic variants seen in a patient are responsible for their disease. tl;dr yes they can: www.biorxiv.org/content/10.1...
biorxiv.org
Evidence Aggregator: AI reasoning applied to rare disease diagnostics
Retrieving, reviewing, and synthesizing technical information can be time-consuming and challenging, particularly when requiring specialized expertise, as is the case of variant assessment for rare di...
114247
Reposted by Kate Thomson
Jodie Ingles @jodieingles27.bsky.social · 05/03/2025
Let me tell you a story about 2 patients we identified, both with a rare variant in TNNT2; NM_001001430.3: c.571-1G>A. Both had cardiac phenotypes and both had Oceanian ancestry Our latest in EHJ! @alexbutters25.bsky.social @escardio.bsky.social #medsky #genechat #cardiosky doi.org/10.1093/eurh...
doi.org
A rare splice-site variant in TNNT2: the need for ancestral diversity in genomic reference data sets
Inherited cardiomyopathies, including hypertrophic (HCM), dilated (DCM), and restrictive (RCM) cardiomyopathies affect ∼1 in 200–500 in the population. Gen
1276
Reposted by Kate Thomson
Jodie Ingles @jodieingles27.bsky.social · 18/02/2025
Q: How many genes should be tested for patients with hypertrophic cardiomyopathy? A: 29 Excited to share our latest: Re-Appraisal of HCM genes by our ClinGen Hereditary CVD Gene Curation Expert Panel out today in @jaccjournals.bsky.social www.sciencedirect.com/science/arti...
sciencedirect.com
Genes Associated With Hypertrophic Cardiomyopathy: A Reappraisal by the ClinGen Hereditary Cardiovascular Disease Gene Curation Expert Panel
Hypertrophic cardiomyopathy (HCM) is an inherited cardiac condition affecting ∼1 in 500 and exhibits marked genetic heterogeneity. Previously publishe…
25428
Reposted by Kate Thomson
Ana Morales, MS, CGC, PhDc @amoralescgc.bsky.social · 16/02/2025
🫀🧬Great work by the Filamin C Registry Consortium! In their multicenter retrospective study, FLNCtv was linked to higher risk of sudden cardiac death (SCD) & malignant ventricular arrhythmia (MVA), especially in probands & phenotype-positive cases. jamanetwork.com/journals/jam...
jamanetwork.com
Arrhythmic Risk Stratification of Carriers of FLNCtv
This cohort study investigates the arrhythmic risk profile of carriers of filamin C truncating variants (FLNCtv) and the risk factors associated with the risk of life-threatening ventricular arrhythmi...
132
Reposted by Kate Thomson
Roddy Walsh 🇪🇺 🇺🇦 @roddywalsh.bsky.social · 01/01/2025
Our study on an SCN5A enhancer variant that is a major cause of Brugada syndrome in Thailand has just been published in the first @ahajournals.bsky.social Circulation issue of 2025 - also now open access! www.ahajournals.org/doi/full/10.... #cardiosky #cardiogen 🧬
ahajournals.org
A Rare Noncoding Enhancer Variant in SCN5A Contributes to the High Prevalence of Brugada Syndrome in Thailand | Circulation
BACKGROUND: Brugada syndrome (BrS) is a cardiac arrhythmia disorder that causes sudden death in young adults. Rare genetic variants in the SCN5A gene encoding the Nav1.5 sodium channel and common nonc...
1106
Reposted by Kate Thomson
European Society of Human Genetics @eshg.bsky.social · 20/12/2024
Announcing new free ESHG webinar series! 🗓️ Last Wednesday of each month 📅 First episode: Feb 26, 2025 (16:00 CET) 🎤 Speaker: Malte Spielmann 💡 Topic: "The Dark Side of the #Genome: Challenges & Opportunities in the Post-Genomic Era" 🔗 Register now: wma.eventsair.com/eshg-webinar...
0138
Reposted by Kate Thomson
Padraig Dixon @padraigdixon.bsky.social · 03/12/2024
The changing landscape of genetics and insurance in the UK - report on an event hosted by the Centre for Personalised Medicine, Oxford and the British Society for Genetic Medicine. bsgm.org.uk/media/12689/...
bsgm.org.uk
041
Reposted by Kate Thomson
Sean @seanlzheng.bsky.social · 21/11/2024
🧬 Our dilated #cardiomyopathy GWAS out today! 📍https://www.nature.com/articles/s41588-024-01952-y All made possible with friends and collaborators from HERMES Consortium @alberthenry.bsky.social @tomlumbers.bsky.social @jamesware.bsky.social @mrc-lms.bsky.social @imperialnhli.bsky.social #BHF 🧵 👇
54323
Reposted by Kate Thomson
Roddy Walsh 🇪🇺 🇺🇦 @roddywalsh.bsky.social · 02/12/2024
A little editorial I wrote for #JACCHF on the challenges of identifying modifier genetic factors for hypertrophic cardiomyopathy. @jaccjournals.bsky.social authors.elsevier.com/a/1kCHM7tD%7... (<- free access link until Jan 21st) #cardiogen
Factors Associated With Phenotypic Variability in HCM
0105